Cyclerion Therapeutics Inc (CYCN) — Financial Flexibility Index
Cyclerion Therapeutics Inc (CYCN) has a Financial Flexibility Index of -0.74x as of June 2026. Free cash flow of $-1.37 Million (operating CF $-1.43 Million minus capex $66.00K) represents -1% of total liabilities ($1.84 Million). Check CYCN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cyclerion Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Cyclerion Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see CYCN operating cash flow.
Annual Financial Flexibility Index for Cyclerion Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Cyclerion Therapeutics Inc. Explore debt repayment capacity of Cyclerion Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.68x | $-3.31 Million | $-3.31 Million | $900.00K | ▲ +38.4% |
| 2024 | -5.98x | $-4.33 Million | $-4.33 Million | $725.00K | ▲ +41.3% |
| 2023 | -10.18x | $-21.25 Million | $-21.25 Million | $2.09 Million | ▼ -91.3% |
| 2022 | -5.32x | $-40.61 Million | $-40.61 Million | $7.63 Million | ▼ -61.7% |
| 2021 | -3.29x | $-36.51 Million | $-36.52 Million | $11.09 Million | ▼ -159.4% |
| 2020 | -1.27x | $-70.97 Million | $-72.49 Million | $55.88 Million | ▼ -18.2% |
| 2019 | -1.07x | $-95.33 Million | $-102.22 Million | $88.75 Million | ▲ +79.6% |
| 2018 | -5.27x | $-94.06 Million | $-97.50 Million | $17.85 Million | ▲ +7.3% |
| 2017 | -5.69x | $-79.81 Million | $-81.22 Million | $14.04 Million | ▼ -24.9% |
| 2016 | -4.55x | $-48.43 Million | $-49.87 Million | $10.64 Million | — |